Sanofi · 1 day ago
Director, External R&D
Swiftwater, PA
Full-time
Onsite
Director/Executive
7+ years expSanofi is an innovative global healthcare company that helps the world stay ahead of infectious diseases by delivering more than 500 million vaccine doses a year. The Director, External R&D will be responsible for sustaining Sanofi Vaccines’ portfolio of new vaccines and developing strategic partnerships with external organizations.
Health CareLife SciencePharmaceuticalTherapeutics
Responsibilities
Proactively scan the external network of companies, academic institutions and government sponsored R&D organizations to identify and evaluate scientific and technological innovations relevant to the business of Sanofi Vaccines
As a member of the ER&D team, develop and maintain the relationships with the vast network of external organizations through various platforms such as participating in partnering meetings and networking conferences, e.g., World Vaccine Congress, BIO, JPMorgan Healthcare, etc
Provide a critical scientific and technical analyses of the external opportunities and collaborate with internal stakeholders (e.g., R&D, Medical Affairs, Franchise Strategy) to formulate the basis for recommendations on the external innovations
Work closely with the Business Development and Legal teams to support business negotiations with potential external partners; provide scientific and technical input to support the constructive negotiations, accurate deal structure evaluations and appropriate deal structure; support the evaluation of the external party's confidential technical/due diligence materials by assembling the evaluation team, coordinating the interactions with the partner and contributing to the final technical due-diligence report
Present to the Vaccines Leadership the outcomes of the assessments arising from the external company engagements to Vaccine Leadership as well as governance committees, including the External Innovation Evaluation Committee (EIEC), Therapeutic Area Review Committee (TARC), as appropriate
Work collaboratively with internal stakeholders (R&D functions, mRNA Center of Excellence, Vaccine Portfolio Strategy, Vaccine Medical Affairs, Vaccine Public Franchise) to align the external engagement strategies with the needs and priorities of the organizations
Work collaboratively with other teams within the External Scientific Affairs (ESA) organization to advance the mission of the ESA, including scouting for licensing/acquisitions, external funding, and vaccine innovation projects
Qualification
Required
M.D. or Ph.D. in bacteriology, virology, immunology, non-infectious disease, or other scientific discipline
7+ years of post-graduate experience
Experience in Vaccines R&D and external partnering preferred
Demonstrated interpersonal skills - ability to work with individuals at different levels and managing through influence
Resourceful, entrepreneurial, and constantly up-to-date with vaccine-relevant innovation opportunities for Sanofi Vaccines
Demonstrated team and negotiation skills
Fluent English communication skills, verbal and written and ability to work in an international context
Up to 15% per year of domestic or international travel
Benefits
High-quality healthcare
Prevention and wellness programs
At least 14 weeks’ gender-neutral parental leave
Company
Sanofi
Sanofi is a global biopharma company focused on prescription drugs, vaccines, and treatments for chronic, rare, and infectious diseases.
10001+ employees
H1B Sponsorship
Sanofi has a track record of offering H1B sponsorships. Please note that this does not
guarantee sponsorship for this specific role. Below presents additional info for your
reference. (Data Powered by US Department of Labor)
Distribution of Different Job Fields Receiving Sponsorship
Represents job field similar to this job
Trends of Total Sponsorships
2025 (101)
2024 (68)
2023 (59)
2022 (78)
2021 (38)
2020 (38)
Funding
Current Stage
Public CompanyTotal Funding
$6.97BKey Investors
Blackstone Life SciencesEvotec
2025-10-28Post Ipo Debt· $3B
2025-06-17Post Ipo Debt· $1.74B
2025-03-05Post Ipo Debt· $1.59B
Leadership Team
Paul Hudson
Chief Executive Officer
Francois-Xavier Roger
Chief Financial Officer
Recent News
2026-01-08
2026-01-08
Company data provided by crunchbase